Galleri MCED (multi-cancer early detect)
Selected indexed studies
- Evaluation of cell-free DNA approaches for multi-cancer early detection. (Cancer Cell, 2022) [PMID:36400018]
- Multi-cancer early detection tests for general population screening: a systematic literature review. (Health Technol Assess, 2025) [PMID:39898371]
- Cell-Free DNA-Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population (NHS-Galleri): Design of a Pragmatic, Prospective Randomised Controlled Trial. (Cancers (Basel), 2022) [PMID:36230741]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Evaluation of cell-free DNA approaches for multi-cancer early detection. (2022) pubmed
- Multi-cancer early detection tests for general population screening: a systematic literature review. (2025) pubmed
- Cell-Free DNA-Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population (NHS-Galleri): Design of a Pragmatic, Prospective Randomised Controlled Trial. (2022) pubmed
- Promises and pitfalls of multi-cancer early detection using liquid biopsy tests. (2025) pubmed
- Clinical referral to the NHS following multi-cancer early detection test results from the NHS-Galleri trial. (2025) pubmed
- Real-world data and clinical experience from over 100,000 multi-cancer early detection tests. (2025) pubmed
- Evaluating multi-cancer early detection tests: an argument for the outcome of recurrence-updated stage. (2023) pubmed
- Modelled mortality benefits of multi-cancer early detection screening in England. (2023) pubmed
- Clinical performance and utility: A microsimulation model to inform the design of screening trials for a multi-cancer early detection test. (2024) pubmed
- Case Report: Multi-cancer early detection utilizing blood-based genomics: Single-institution case series of novel cancer screening. (2025) pubmed